Michael Lilly

Trials

Studies that name Michael Lilly as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:02 UTC. Open this list on ClinicalTrials.gov

• Ph2
  NCT04207255 · Addition of Opaganib to Androgen Antagonists in Patients With mCRPC

  Medical University of South Carolina · completed · Prostate Cancer · principal investigator
• Ph1/Ph2
  NCT03712371 · Study of Chitosan for Pharmacologic Manipulation of AGE Levels in Prostate Cancer Patients

  Medical University of South Carolina · terminated · Prostate Cancer · principal investigator
• N/A
  NCT03677076 · Clonal Emergence and Regression During Radium-223 Therapy for Metastatic Prostate Cancer

  Medical University of South Carolina · completed · Prostate Cancer · principal investigator
• Ph1
  NCT03465345 · Study of Metformin Plus Oligomeric Procyanidin Complex for Pharmacologic Manipulation of AGE (Advanced Glycation Endproducts) Levels in Prostate Cancer Patients

  Medical University of South Carolina · withdrawn · Prostate Cancer · principal investigator
• Ph2
  NCT03149159 · Investigator-Initiated Trial of Combined Ipilimumab, Nivolumab and Stereotactic Radiation in Patients With Metastatic Clear-Cell RCC (ccRCC) Who Have Failed Treatment With Single-Agent Nivolumab

  Medical University of South Carolina · withdrawn · Clear Cell Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma · principal investigator
• Ph1
  NCT03092635 · AGE Levels in ER+ Metastatic Breast Cancer Patients Receiving Endocrine Therapy

  Medical University of South Carolina · terminated · Breast Cancer · principal investigator
• Ph2
  NCT02946996 · Study of Pharmacologic Manipulation of AGE (Advanced Glycation Endproducts) Levels in Prostate Cancer Patients Receiving Androgen Deprivation Therapy

  Medical University of South Carolina · terminated · Prostate Cancer · principal investigator
• Ph2
  NCT02772562 · Adjuvant PROSTVAC-V/F in Subjects at High Risk for Relapse After Radical Prostatectomy

  Medical University of South Carolina · terminated · Prostatic Neoplasms · principal investigator
• Ph1
  NCT01949519 · Docetaxel and Lycopene in Metastatic Prostate Cancer

  Medical University of South Carolina · completed · Adenocarcinoma of the Prostate · principal investigator
• Ph1
  NCT01820299 · Phase I Assay-guided Trial of Anti-inflammatory Phytochemicals in Patients With Advanced Cancer

  Medical University of South Carolina · completed · Solid Cancers · principal investigator
• Ph1/Ph2
  NCT01335204 · Ph Ib/IIa Study of Cabazitaxel Plus Bavituximab in Castration-resistant Prostate Cancer

  Medical University of South Carolina · terminated · Prostate Cancer, Prostatic Neoplasms · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-11 23:02 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 8 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.

• Medical University of South Carolina Transdisciplinary Collaborative Center in Precision Medicine and Minority Men's Health
  U54MD010706 · NIMHD · UNIVERSITY OF SOUTHERN CALIFORNIA · fiscal years 2016 to 2020 · $1,325,883 awarded in 2020
  Same name and institution; not confirmed by an ID
• A Phase 1b Trial of Oligomeric Procyanidin Complex in Combination with Metformin for Reduced AGE Levels in Prostate Cancer Patients Receiving Androgen Deprivation Therapy
  U54CA210962 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · fiscal years 2017 to 2019 · $72,216 awarded in 2019
  Same name and institution; not confirmed by an ID
• MUSC/HCC Paul Calabresi Clinical Oncology Career Development Program
  K12CA157688 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · fiscal years 2013 to 2019 · $244,971 awarded in 2019
  Same name and institution; not confirmed by an ID
• Phase 1 Bioassay-guided Trial of Lycopene and Docetaxel for Prostate Cancer
  R21CA166839 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · fiscal years 2013 to 2014 · $159,412 awarded in 2014
  Grant number is on one of their registry trials

NIH grants that fund their trials

These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.

• Project 3: Targeting SK2/S1P Signaling for the Regulation of c-Myc and Tumor Suppression
  P01CA203628 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI Carolyn D Britten · fiscal years 2016 to 2021
  Named on NCT04207255